MYERS SCOTT DUNSETH received a stock award from ZENTALIS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/18/2026ACC: 0001356256-26-000005
Director
Since Nov 2024
+57.10K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
57.10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+57.10K
Price / share
—
Trade value
—
% of position
16.9%
6/16/2026
338.80K→395.89K
Total
Net shares
+57.10K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/16/2026 | A · Award | +57.10K | — | — | 16.9% | 338.80K | 395.89K |
| Total | +57.10K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported